Heart failure with preserved ejection fraction may be driven primarily by dysfunctional visceral fat and harmful adipokines—shifting screening toward waist‑to‑height ratio and treatment toward fat‑targeting therapies, including GLP‑1 agents. ✨ What’s new 🧠 Fat biology over pressure 🧍 Who’s at risk (beyond BMI) 💊 Treatment implications 📏 How to measure (simple and scalable) 🧪 Why […]
